ORDERING INFORMATION
Catalog No. | Clone No. | MAb Subtype | Size | Library Pack No. | 100ug/clone |
16601 | LC10-136.4 | IgG1 | 100ug, 500ug | 166101 | All 5 clones |
16602 | LC11-222.4 | IgG1 | 100ug, 500ug | ||
16603 | LC11-251.3.6 | IgG1 | 100ug, 500ug | ||
16604 | LC11-378.5 | IgG1 | 100ug, 500ug | ||
16605 | LC12-402.3 | IgG1 | 100ug, 500ug |
Format: Protein G-purified antibody in PBS, pH 7.4.
BACKGROUND
Lidocaine, also known as xylocaine and lignocaine, is a medication used to numb tissue in a specific area. The efficacy of lidocaine as a local anesthetic is characterized by a rapid onset of action and intermediate duration of efficacy. Lidocaine is also the most important class-1b antiarrhythmic drug; it is used intravenously for the treatment of ventricular arrhythmias. Lidocaine was discovered in 1946 and is on the WHO Model List of Essential Medicines.
SPECIFICATION SUMMARY
Antigen: Lidocaine conjugated to KLH.
Host Species: Mouse
Specificity: These antibodies recognize lidocaine.
APPLICATIONS
These antibodies have been qualified for use in ELISA to detect lidocaine.
DILUTION INSTRUCTIONS
Dilute in PBS or medium that is identical to that used in the assay system.
STORAGE AND STABILITY
These antibodies are stable for at least one (1) year at -20oC to -70oC. Store product in appropriate aliquots to avoid multiple freeze-thaw cycles.
For in vitro investigational use only. Not for use in therapeutic or diagnostic procedures.